96 related articles for article (PubMed ID: 17203872)
1. Estimation of DNA damage and cytotoxicity of anthracycline analogs in human melanoma cells on early and late passages.
Anuszewska E; Chłopkiewicz B; Gruber B; Marczewska J; Priebe W; Skurzak H
Acta Pol Pharm; 2006; 63(4):321-4. PubMed ID: 17203872
[TBL] [Abstract][Full Text] [Related]
2. Effect of structural modification at the 4, 3', and 2' positions of doxorubicin on topoisomerase II poisoning, apoptosis, and cytotoxicity in human melanoma cells.
Gruber BM; Anuszewska EL; Bubko I; Goździk A; Fokt I; Priebe W
Arch Immunol Ther Exp (Warsz); 2007; 55(3):193-8. PubMed ID: 17557149
[TBL] [Abstract][Full Text] [Related]
3. DNA damage induced by the anthracycline cosmomycin D in DNA repair-deficient cells.
Carvalho H; Garrido LM; Furlan RL; Padilla G; Agnoletto M; Guecheva T; Henriques JA; Saffi J; Menck CF
Cancer Chemother Pharmacol; 2010 Apr; 65(5):989-94. PubMed ID: 20107801
[TBL] [Abstract][Full Text] [Related]
4. Membrane gamma-glutamyl transferase activity promotes iron-dependent oxidative DNA damage in melanoma cells.
Corti A; Duarte TL; Giommarelli C; De Tata V; Paolicchi A; Jones GD; Pompella A
Mutat Res; 2009 Oct; 669(1-2):112-21. PubMed ID: 19505483
[TBL] [Abstract][Full Text] [Related]
5. Studies on the mechanisms of an H2O2 adaptive dose on DNA damage in human neoplastic cells treated with adriamycin.
Gruber BM; Anuszewska EL
Acta Pol Pharm; 2000; 57(3):193-8. PubMed ID: 11143708
[TBL] [Abstract][Full Text] [Related]
6. NFkappaB activation and drug sensitivity in human neoplastic cells treated with anthracyclines.
Gruber BM; Anuszewska EL; Bubko I; Kasprzycka-Guttman T; Misiewicz I; Skupińska K; Fokt I; Piebe W
Acta Pol Pharm; 2008; 65(2):267-71. PubMed ID: 18666436
[TBL] [Abstract][Full Text] [Related]
7. Lichen metabolites prevent UV light and nitric oxide-mediated plasmid DNA damage and induce apoptosis in human melanoma cells.
Russo A; Piovano M; Lombardo L; Garbarino J; Cardile V
Life Sci; 2008 Sep; 83(13-14):468-74. PubMed ID: 18721817
[TBL] [Abstract][Full Text] [Related]
8. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
9. Genista sessilifolia DC. and Genista tinctoria L. inhibit UV light and nitric oxide-induced DNA damage and human melanoma cell growth.
Rigano D; Cardile V; Formisano C; Maldini MT; Piacente S; Bevelacqua Y; Russo A; Senatore F
Chem Biol Interact; 2009 Jul; 180(2):211-9. PubMed ID: 19497419
[TBL] [Abstract][Full Text] [Related]
10. The cardio-protecting agent and topoisomerase II catalytic inhibitor sobuzoxane enhances doxorubicin-DNA adduct mediated cytotoxicity.
Swift LP; Cutts SM; Nudelman A; Levovich I; Rephaeli A; Phillips DR
Cancer Chemother Pharmacol; 2008 Apr; 61(5):739-49. PubMed ID: 17594094
[TBL] [Abstract][Full Text] [Related]
11. Effect of melatonin on cytotoxicity of doxorubicin toward selected cell lines (human keratinocytes, lung cancer cell line A-549, laryngeal cancer cell line Hep-2).
Fic M; Podhorska-Okolow M; Dziegiel P; Gebarowska E; Wysocka T; Drag-Zalesinska M; Zabel M
In Vivo; 2007; 21(3):513-8. PubMed ID: 17591362
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity and cellular uptake of doxorubicin and its formamidine derivatives in HL60 sensitive and HL60/MX2 resistant cells.
Kik K; Wasowska-Lukawska M; Oszczapowicz I; Szmigiero L
Anticancer Res; 2009 Apr; 29(4):1429-33. PubMed ID: 19414398
[TBL] [Abstract][Full Text] [Related]
13. Anticlastogenic and antigenotoxic effects of selenomethionine on doxorubicin-induced damage in vitro in human lymphocytes.
Santos RA; Takahashi CS
Food Chem Toxicol; 2008 Feb; 46(2):671-7. PubMed ID: 17961897
[TBL] [Abstract][Full Text] [Related]
14. Zinc differentially modulates DNA damage induced by anthracyclines in normal and cancer cells.
Wysokinski D; Blasiak J; Wozniak K
Exp Oncol; 2012 Dec; 34(4):327-31. PubMed ID: 23302990
[TBL] [Abstract][Full Text] [Related]
15. In vivo Comet assay on isolated kidney cells to distinguish genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Nesslany F; Zennouche N; Simar-Meintières S; Talahari I; Nkili-Mboui EN; Marzin D
Mutat Res; 2007 Jun; 630(1-2):28-41. PubMed ID: 17507283
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines.
Chłopkiewicz B; Ejchart A; Marczewska J; Anuszewska E; Priebe W
Acta Pol Pharm; 2005; 62(2):99-104. PubMed ID: 16161349
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
[TBL] [Abstract][Full Text] [Related]
18. Effect of bixin on DNA damage and cell death induced by doxorubicin in HL60 cell line.
Santos GC; Almeida MR; Antunes L; Bianchi M
Hum Exp Toxicol; 2016 Dec; 35(12):1319-1327. PubMed ID: 26860686
[TBL] [Abstract][Full Text] [Related]
19. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
Pastorino F; Mumbengegwi DR; Ribatti D; Ponzoni M; Allen TM
J Control Release; 2008 Feb; 126(1):85-94. PubMed ID: 18166243
[TBL] [Abstract][Full Text] [Related]
20. Anthracycline-induced cytotoxicity in the GL261 glioma model system.
Tavener AM; Phelps MC; Daniels RL
Mol Biol Rep; 2021 Jan; 48(1):1017-1023. PubMed ID: 33387196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
